Development of novel, well-tolerated, TNIP1-specific acne therapeutic modalities could potentially reduce inflammation without the harmful side effects of currently available treatment options (antibiotic, retinoid or hormonal formulation usage). The gene discussed is TNIP1; the disease is acne.